CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing.

Due to the strong sequence homology it has been suggested that CDC2L5 and CDK12 belong to a high molecular weight subfamily of CDC2 family with PITAI/VRE motifs [F. Marques, J.L. Moreau, G. Peaucellier, J.C. Lozano, P. Schatt, A. Picard, I. Callebaut, E. Perret, A.M. Geneviere, A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE motifs, Biochem. Biophys. Res. Commun. 279 (2000) 832-837]. Recently, we reported that CDK12 interacts with L-type cyclins and is involved in alternative splicing regulation [H.-H. Chen, Y.-C. Wang, M.-J. Fann, Identification and characterization of the CDK12/Cyclin L1 complex involved in alternative splicing regulation, Mol. Cel. Biol. 26 (2006) 2736-2745]. Here, we provide evidence that CDC2L5 also interacts with L-type cyclins and thus rename it as cyclin-dependent kinase 13 (CDK13). The kinase domain of CDK13 is sufficient to bind the cyclin domains of L-type cyclins. Moreover, CDK13 and L-type cyclins modulate each other's subcellular localization. When CDK13 and an E1a minigene reporter construct were over-expressed in HEK293T cells, CDK13 alters the splicing pattern of E1a transcripts in a dose-dependent manner. Similar to effects of CDK12, effects of CDK13 on splicing pattern are counteracted by SF2/ASF and SC35. These findings strengthen CDK12 and CDK13 as a subfamily of cyclin-dependent kinases that regulate alternative splicing.

[1]  J. Gottesfeld,et al.  Cyclin L Is an RS Domain Protein Involved in Pre-mRNA Splicing* , 2002, The Journal of Biological Chemistry.

[2]  Konrad Büssow,et al.  Characterization of Cyclin L2, a Novel Cyclin with an Arginine/Serine-rich Domain , 2004, Journal of Biological Chemistry.

[3]  Tom Maniatis,et al.  Specific interactions between proteins implicated in splice site selection and regulated alternative splicing , 1993, Cell.

[4]  B. Graveley.  Alternative splicing: increasing diversity in the proteomic world. , 2001, Trends in genetics : TIG.

[5]  William Arbuthnot Sir Lane,et al.  A serine kinase regulates intracellular localization of splicing factors in the cell cycle , 1994, Nature.

[6]  M. Hagiwara,et al.  Cloning of Human PRP4 Reveals Interaction with Clk1* , 2001, The Journal of Biological Chemistry.

[7]  Bosiljka Tasic,et al.  Alternative pre-mRNA splicing and proteome expansion in metazoans , 2002, Nature.

[8]  J. Valcárcel,et al.  Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.

[9]  J. Tazi,et al.  Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor. , 1998, Nucleic acids research.

[10]  Nan Li,et al.  Cyclin L2, a Novel RNA Polymerase II-associated Cyclin, Is Involved in Pre-mRNA Splicing and Induces Apoptosis of Human Hepatocellular Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[11]  J. Cheng,et al.  Molecular and Genetic Studies Imply Akt-mediated Signaling Promotes Protein Kinase CβII Alternative Splicing via Phosphorylation of Serine/Arginine-rich Splicing Factor SRp40* , 2005, Journal of Biological Chemistry.

[12]  J. Pines,et al.  CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles. , 2001, Journal of cell science.

[13]  A. Hartmann,et al.  The interaction and colocalization of Sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the Src family kinase p59(fyn). , 1999, Molecular biology of the cell.

[14]  L. Cantley,et al.  SRPK2: A Differentially Expressed SR Protein-specific Kinase Involved in Mediating the Interaction and Localization of Pre-mRNA Splicing Factors in Mammalian Cells , 1998, The Journal of cell biology.

[15]  B. Blencowe.  Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. , 2000, Trends in biochemical sciences.

[16]  T Pawson,et al.  The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. , 1996, The EMBO journal.

[17]  M. Hagiwara,et al.  cdc2 kinase-mediated phosphorylation of splicing factor SF2/ASF. , 1998, Biochemical and biophysical research communications.

[18]  J. Manley,et al.  Determinants of SR protein specificity. , 1999, Current opinion in cell biology.

[19]  Hung-Hsi Chen,et al.  Identification and Characterization of the CDK12/Cyclin L1 Complex Involved in Alternative Splicing Regulation , 2006, Molecular and Cellular Biology.

[20]  Xiang-Dong Fu,et al.  Phosphorylation Regulates In Vivo Interaction and Molecular Targeting of Serine/Arginine-rich Pre-mRNA Splicing Factors , 1999, The Journal of cell biology.

[21]  J. Manley,et al.  Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. , 1997, Genes & development.

[22]  Y. Even,et al.  CDC2L5, a Cdk‐like kinase with RS domain, interacts with the ASF/SF2‐associated protein p32 and affects splicing in vivo , 2006, Journal of cellular biochemistry.

[23]  T. Cooper,et al.  RNA processing and human disease , 2000, Cellular and Molecular Life Sciences CMLS.

[24]  A. Genevière,et al.  A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE motifs. , 2000, Biochemical and biophysical research communications.

[25]  B. Graveley.  Sorting out the complexity of SR protein functions. , 2000, RNA.

[26]  M. Hagiwara,et al.  Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles. , 1998, Biochemical and biophysical research communications.